Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACONW Aclarion	$0.05 -0.4%	$0.03	$0.01 ▼ $0.24	N/A	N/A	32,706 shs	10,255 shs
AONC American Oncology Network	$11.99 +8.4%	$11.70	$2.10 ▼ $14.25	N/A	N/A	2,958 shs	340 shs
OPGN OpGen	$0.00	$3.16	$0.00 ▼ $0.00	$1K	-1.77	8,717 shs	1,920 shs
UPHL UpHealth	$0.00	$0.00	$0.00 ▼ $0.41	$4K	0.85	5,903 shs	161 shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACONW Aclarion	+15.65%	+7.84%	+46.88%	+57.14%	+62.83%
AONC American Oncology Network	-10.81%	+5.33%	+0.55%	+81.31%	+251.11%
OPGN OpGen	0.00%	0.00%	-100.00%	-100.00%	-99.99%
UPHL UpHealth	0.00%	0.00%	0.00%	-33.33%	-99.94%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ACONW Aclarion	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
AONC American Oncology Network	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OPGN OpGen	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
UPHL UpHealth	0.364 of 5 stars	0.0	2.0	0.0	0.0	0.0	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACONW Aclarion	N/A	N/A	N/A
AONC American Oncology Network	N/A	N/A	N/A
OPGN OpGen	N/A	N/A	N/A
UPHL UpHealth	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACONW Aclarion	$62.95K	N/A	N/A	N/A	N/A	N/A
AONC American Oncology Network	$1.34B	N/A	N/A	N/A	N/A	N/A
OPGN OpGen	$2.67M	0.00	N/A	N/A	($11.55) per share	0.00
UPHL UpHealth	$130M	0.00	N/A	N/A	$3.10 per share	0.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACONW Aclarion	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
AONC American Oncology Network	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
OPGN OpGen	-$32.67M	N/A	0.00	∞	N/A	-1,140.36%	N/A	-287.58%	N/A
UPHL UpHealth	-$56.42M	-$1.35	N/A	∞	N/A	N/A	N/A	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACONW Aclarion	N/A	N/A	N/A	N/A	N/A
AONC American Oncology Network	N/A	N/A	N/A	N/A	N/A
OPGN OpGen	N/A	N/A	N/A	N/A	N/A
UPHL UpHealth	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACONW Aclarion	N/A	N/A	N/A
AONC American Oncology Network	N/A	N/A	N/A
OPGN OpGen	N/A	5.45	5.45
UPHL UpHealth	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ACONW Aclarion	N/A
AONC American Oncology Network	N/A
OPGN OpGen	2.68%
UPHL UpHealth	56.10%

Insider Ownership

Company	Insider Ownership
ACONW Aclarion	N/A
AONC American Oncology Network	N/A
OPGN OpGen	43.80%
UPHL UpHealth	34.24%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ACONW Aclarion	7	N/A	N/A	Not Optionable
AONC American Oncology Network	1,520	N/A	N/A	Not Optionable
OPGN OpGen	100	10.07 million	4.70 million	Not Optionable
UPHL UpHealth	1,750	18.93 million	12.45 million	No Data

OPGN, UPHL, ACONW, and AONC Headlines

Recent News About These Companies

UpHealth Delays Q2 2025 10-Q Filing

August 14, 2025 | msn.com

UpHealth, Inc. (UPHL) Latest Stock News & Headlines - Yahoo Finance

April 23, 2025 | finance.yahoo.com

Lemon Dump Cake Recipe

September 9, 2024 | msn.com

DJUSIV Dow Jones US Business Support Services Index

July 27, 2024 | seekingalpha.com

UpHealth Inc Ordinary Shares UPHL

July 19, 2024 | morningstar.comM

UpHealth Holdings, Inc. Wins Ruling in Calcutta High Court, Mandating All Glocal Healthcare Respondents Submit Affidavits of Assets

May 24, 2024 | prnewswire.com

UpHealth, Inc. (UPHL) Advances While Market Declines: Some Information for Investors

April 30, 2024 | zacks.com

UpHealth, Inc. (UPHL)

April 17, 2024 | finance.yahoo.com

Calcutta High Court rules in favour of UpHealth Holdings, Inc., and vigorously reinforces the ICC International Court of Arbitration previous $110 million award against Glocal directors and other Respondents, calling their conduct “dishonest and fraudulent”

April 16, 2024 | finance.yahoo.com

UpHealth Holdings Takes Steps to Enforce the International Court of Arbitration’s Final Award to UpHealth Holdings of more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare Systems

April 1, 2024 | finance.yahoo.com

UpHealth, Inc.: UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial Results

March 22, 2024 | finanznachrichten.de

UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial Results

March 21, 2024 | finance.yahoo.com

Healthcare Triangle GAAP EPS of -$1.26, revenue of $7.1M

March 18, 2024 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPGN, UPHL, ACONW, and AONC Company Descriptions

Aclarion NASDAQ:ACONW

$0.05 0.00 (-0.40%)

As of 03:07 PM Eastern

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

American Oncology Network NASDAQ:AONC

$11.99 +0.93 (+8.41%)

As of 03:09 PM Eastern

American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.

OpGen NASDAQ:OPGN

$0.0001 0.00 (0.00%)

As of 10:46 AM Eastern

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.

UpHealth NYSE:UPHL

$0.0002 0.00 (0.00%)

As of 08/20/2025 03:07 PM Eastern

UpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas. The company offers mental health and substance use disorder treatment services directly to consumers. It also provides detoxification, residential, partial hospitalization program, intensive outpatient program, outpatient services, and non-clinical recovery residence and supporting housing services. UpHealth, Inc. is headquartered in Delray Beach, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time